Ahmad Anjak , MD

Medical Degree: University of Aleppo 1996

Internship: University of Aleppo 1997 (Diagnostic Radiology)

Internship : New York Methodist Hospital/Cornell University Medical College 1999 (Internal Medicine)

Residency: St. Luke's Hospital/St. Louis University School of Medicine 2001 (Internal Medicine)

Fellowship: University of Cincinnati 2011 (Cardiac Imaging)

Fellowship: University of Cincinnati Cincinnati, Ohio, 2018 (Nephrology)

American Board of Internal Medicine (Nephrology) (Certification Date: 10-03-2018 )

American Board of Internal Medicine (Certification Date: 08-21-2001 ) - (Recertification Date: to 01-01-2023 )

Internal Medicine

Nephrology

Internal Medicine

Nephrology

Nephrology
Glomerulonephritis Disease

Grant: #417-201-00007 Investigators:Anjak, Ahmad 05-18-2023 -05-18-2026 Syneos Health, LLC A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Subjects with Immunoglobulin A Nephropath Role:PI 217507.00 Hold Level:Industry

Grant: #VT-001-0050 Investigators:Anjak, Ahmad 08-22-2023 -09-18-2029 Vera Therapeutics, Inc A Phase 2b/3, Multi-part, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Atacicept in Subjects with IgA Nephropathy (IgAN) (ORIGIN 3) Role:PI 273782.09 Hold Level:Industry

Peer Reviewed Publications

Haghighi, Kobra; Pritchard, Tracy; Bossuyt, Julie; Waggoner, Jason R; Yuan, Qunying; Fan, Guo-Chang; Osinska, Hanna; Anjak, Ahmad; Rubinstein, Jack; Robbins, Jeffrey; Bers, Donald M; Kranias, Evangelia G (2011. ) The human phospholamban Arg14-deletion mutant localizes to plasma membrane and interacts with the Na/K-ATPase.Journal of molecular and cellular cardiology, , More Information

Anjak, Ahmad; López-Candales, Angel; Lopez, Francisco R; Harris, David; Elwing, Jean (2014. ) Objective measures of right ventricular function during exercise: results of a pilot study.Echocardiography (Mount Kisco, N.Y.), , 31 (4 ) ,508-15 More Information

Pritchard, Tracy J; Kawase, Yoshiaki; Haghighi, Kobra; Anjak, Ahmad; Cai, Wenfeng; Jiang, Min; Nicolaou, Persoulla; Pylar, George; Karakikes, Ioannis; Rapti, Kleopatra; Rubinstein, Jack; Hajjar, Roger J; Kranias, Evangelia G (2013. ) Active inhibitor-1 maintains protein hyper-phosphorylation in aging hearts and halts remodeling in failing hearts.PloS one, , 8 (12 ) ,e80717 More Information

Basford, Joshua E; Koch, Sheryl; Anjak, Ahmad; Singh, Vivek P; Krause, Eric G; Robbins, Nathan; Weintraub, Neal L; Hui, David Y; Rubinstein, Jack (2013. ) Smooth muscle LDL receptor-related protein-1 deletion induces aortic insufficiency and promotes vascular cardiomyopathy in mice.PloS one, , 8 (11 ) ,e82026 More Information

Koch, Sheryl E; Haworth, Kevin J; Robbins, Nathan; Smith, Margaret A; Lather, Navneet; Anjak, Ahmad; Jiang, Min; Varma, Priyanka; Jones, W Keith; Rubinstein, Jack (2013. ) Age- and gender-related changes in ventricular performance in wild-type FVB/N mice as evaluated by conventional and vector velocity echocardiography imaging: a retrospective study.Ultrasound in medicine & biology, , 39 (11 ) ,2034-43 More Information

Florea, Stela; Anjak, Ahmad; Cai, Wen-Feng; Qian, Jiang; Vafiadaki, Elizabeth; Figueria, Sarah; Haghighi, Kobra; Rubinstein, Jack; Lorenz, John; Kranias, Evangelia G (2012. ) Constitutive phosphorylation of inhibitor-1 at Ser67 and Thr75 depresses calcium cycling in cardiomyocytes and leads to remodeling upon aging.Basic research in cardiology, , 107 (5 ) ,279 More Information

Academic - Medical Sciences Building
Room 6102
Cincinnati  Ohio, 45267-0535
Phone: 513-558-5471
Fax: 513-558-4309
ahmad.anjak@uc.edu